Related topics: Industry, Nutritional lipids and oils, Cardiovascular health
Israeli-based lipid specialist, Enzymotec, has been granted a home turf patent for the composition and production of its phytosterol ingredient, Cardiobeat.
The patent follows previous approvals granted in China and New Zealand as well as new dietary ingredient status in the US and novel food approval in the European Union.
Further process and efficacy patents are pending in other international jurisdictions.
CardiaBeat, derived from an omega-3 glyceride matrix, has been shown to reduce the likelihood of cardiovascular disease in clinical trials.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
